Since these three CSF biomarkers reflect key elements of AD pathophysiology, i.e., neuronal degeneration (T-tau), tau pathology (P-tau), and amyloid plaques (Aβ42), they are often termed the “core” AD biomarkers (Hampel et al., 2004). Here, MAPT is linked to Alzheimer disease.